Vivos Therapeutics Inc (VVOS) Company Profile & Statistics

Vivos Therapeutics Inc
VVOS
(Nasdaq - US)
N/A
2.48
+0.47 (+23.13%)
in:usd•As of: May 14, 2024 15:59 UTC -4
After Market:2.08-0.39 (-15.96%)
Open
2.17
High
2.54
Low
2.17

About Vivos Therapeutics Inc

CEO

R. Kirk Huntsman

Headquarters

7921 southpark plaza, suite 210

littleton, co 80120, united states

Auditor

Moss Adams, LLP

Employees

114

Share Holders

7,309

Website

www.vivos.com

Industry

medical specialties

Sector

health technology

Company Overview

Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered breathing comprising mild-to-moderate obstructive sleep apnea. Vivos Therapeutics Inc. is based in Highlands Ranch, Colorado.

Vivos Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	7.38M
Enterprise Value	5.73M
Enterprise Value/EBITDA (ttm)	-0.34
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	9.48
Price to Sales (ttm)	0.46
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	59.89%
Operating Margin (ttm)	-115.14%
Profit Margin (ttm)	-100.38%
Return on Equity (ttm)	-665.17%
Return on Invested Capital (ttm)	-5873.09%
Return on Assets (ttm)	-122.48%

Income Statement

Revenue (ttm)	13.80M
Revenue Per Share (ttm)	5.05
Gross Profit (ttm)	8.27M
EBITDA (ttm)³	-16.67M
Net Income Avi to Common (ttm)	-13.58M
Diluted EPS (ttm)	-11.05

Share Statistics

Beta (5Y Monthly)	8.03
52-Week Change	-70.00%
S&P500 52-Week Change	26.85%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	2.73M
Dividend Yield	0.00%
Float ⁴	2.70M
% Held by Insiders	9.60%
% Held by Institutions	26.35%

Balance Sheet

Total Cash (mrq)	1.64M
Total Cash Per Share (mrq)	0.60
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	0.34%
Quick Ratio (mrq)	0.34%
Book Value Per Share (mrq)	0.22

Cash Flow

Operating Cash Flow Per Share (ytd)	-9.80
Free Cash Flow (ytd)	-12.75M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Vivos Therapeutics Inc

Trade With A Regulated Broker